In the rapidly evolving and competitive biotech industry, where innovation and financial performance are inextricably linked, savvy CFOs must adopt a long-term perspective to navigate the complex, often decade-long journey of drug commercialization, says Karl Dorwart, vice president, head of healthcare, life sciences and consumer staples at Factor, an integrated law provider.